ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
121.677,84
-0,29%
S&P 500
5.295,61
0,23%
US Dollar vs BRL
5,2919
0,79%
Bitcoin
70.813,12
2,92%
Brent Oil
77,61
-0,68%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. RenovoRx Inc (RNXT)

  7. RenovoRx Inc (RNXT) Notícias

RNXT

RenovoRx (RNXT)

RenovoRx Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:RNXT
DataHoraFonteTítuloCódigoCompanhia
30/05/202409:30Business WireRenovoRx CEO Issues Update Letter to ShareholdersNASDAQ:RNXTRenovoRx Inc
21/05/202410:00Business WirePublication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment DeliveryNASDAQ:RNXTRenovoRx Inc
14/05/202410:00Business WireRenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024NASDAQ:RNXTRenovoRx Inc
13/05/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RNXTRenovoRx Inc
10/05/202418:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RNXTRenovoRx Inc
10/05/202417:50Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RNXTRenovoRx Inc
02/05/202410:00Business WireRenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024NASDAQ:RNXTRenovoRx Inc
18/04/202409:30Business WireRenovoRx Regains Compliance with Nasdaq Stockholders’ Equity RequirementNASDAQ:RNXTRenovoRx Inc
16/04/202409:30Business WireRenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific MeetingNASDAQ:RNXTRenovoRx Inc
15/04/202409:00Business WireRenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026NASDAQ:RNXTRenovoRx Inc
08/04/202409:30Business WireRenovoRx Announces $11.1 Million at Market Private PlacementNASDAQ:RNXTRenovoRx Inc
05/04/202409:30Business WireRenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024NASDAQ:RNXTRenovoRx Inc
12/03/202410:00Business WireRenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024NASDAQ:RNXTRenovoRx Inc
08/03/202418:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
08/03/202418:26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RNXTRenovoRx Inc
08/03/202418:05Business WireRenovoRx Highlights Key Leadership PromotionsNASDAQ:RNXTRenovoRx Inc
09/02/202418:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNXTRenovoRx Inc
09/02/202418:15Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:RNXTRenovoRx Inc
06/02/202410:30Business WireRenovoRx CEO Issues Letter to ShareholdersNASDAQ:RNXTRenovoRx Inc
29/01/202410:30Business WireRenovoRx Closes $6.1 Million Private PlacementNASDAQ:RNXTRenovoRx Inc
21/12/202310:30Business WireRenovoRx Engages Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct CancerNASDAQ:RNXTRenovoRx Inc
19/12/202310:30Business WireRenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific MeetingNASDAQ:RNXTRenovoRx Inc
13/12/202310:31Business WireRenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy PlatformNASDAQ:RNXTRenovoRx Inc
27/11/202315:23Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:RNXTRenovoRx Inc
17/11/202319:30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:RNXTRenovoRx Inc
16/11/202310:35Business WireRenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.NASDAQ:RNXTRenovoRx Inc
14/11/202310:30Business WireRenovoRx Reports Third Quarter 2023 Financial Results and Operational HighlightsNASDAQ:RNXTRenovoRx Inc
02/10/202309:30Business WireRenovoRx to Present at the ROTH MKM Healthcare Opportunities Conference on October 12, 2023NASDAQ:RNXTRenovoRx Inc
17/08/202309:30Business WireRenovoRx Reports Second Quarter 2023 Financial Results and Operational HighlightsNASDAQ:RNXTRenovoRx Inc
15/08/202316:57Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:RNXTRenovoRx Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:RNXT

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
GFSA3
GAFISA ON
BOV
AZEV4
AZEVEDO PN
BOV
OIBR3
OI ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
RCSL3
RECRUSUL ON
BOV
AMER3
Americanas ON
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
MEAL3
IMC S/A ON
BOV
RCSL4
RECRUSUL PN
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
COGN3
COGNA ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
GOLL4
GOL PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados